Trials / Conditions / Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)
Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)
3 registered clinical trials studyying Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL NCT07301424 | University of Alberta | Phase 2 |
| Recruiting | Newly-diagnosed Pediatric Ph-positive B-ALL Protocol NCT07152041 | Institute of Hematology & Blood Diseases Hospital, China | Phase 3 |
| Suspended | Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (A NCT01222013 | Renato Melaragno | Phase 2 |